The Depo Provera birth control injection has been linked to the serious side effect of an increased risk of breast cancer. Our firm is working with experienced Depo Provera lawyers across the country, who can help you pursue a claim and/or Depo Provera lawsuit and charge no legal fees until you receive an award or settlement. Visit us online or call us toll free anytime for a free legal consultation.
Depo Provera Side Effects: Increased Breast Cancer Risk
The FDA eventually approved Depo-Provera (depo-medroxyprogesterone acetate) in October 1992, after having denied it on two occasions; once in 1972, and again in 1975. The contraceptive is manufactured by Pfizer and is taken to prevent pregnancy. The medication is a progestin-only birth control shot that prevents pregnancy by halting ovulation in the female taking it. The shots are administered once every three months for a total of four shots annually. The drug was first linked to breast cancer in 2004. An April 2012 study published in the Cancer Research Journal examined the link between these injections and breast cancer and revealed that approximately 3.1 percent of young women diagnosed with breast cancer had used the contraceptive within the preceding five years.
Pfizer marketed the drug to prevent pregnancy; however, studies have shown that this risk for developing breast cancer is present in young women who use the shot for a year or longer. Using the contraceptive injection for a year or more has been shown to double the likelihood of developing breast cancer whereas women who used the drug for less than one year did not show any increased likelihood of developing breast cancer. To learn more, you can access the study here.
Medical Studies Regarding Depo Provera
Researchers with the Fred Hutchinson Cancer Research Center conducted a study to evaluate the relationship between Depo Provera use and its link to breast cancer in young women. The study revealed that women who take Depo Provera for over one year are 2.2 times more likely to develop certain types of breast cancer, such as:
- Invasive Ductal Carcinoma (IDC) – This condition causes cancer cells to grow in the milk ducts of the breast and then later spread to other parts of the breast tissue. Usually detected as a lump, this type of cancer may stay confined to the breast tissue, or spread to other tissues in the body.
- Invasive Lobular Carcinoma (ILC) – This condition is a much rarer form of breast cancer, usually detected as a mass or thickening in the woman’s breast tissue.
To view more about the Fred Hutchinson Cancer Research Center study, click here.
FDA Warnings Regarding Depo Provera
In October 2012, the FDA’s Center for Drug Evaluation and Research approved changes to the drug’s safety labeling, including a warning for breast cancer. The precaution stated that women who currently have breast cancer or were diagnosed with breast cancer and had the disease in the past, should not use hormone contraceptives such as Depo Provera, because breast cancer may be a hormonally sensitive condition. The FDA advised that women with a family history of breast cancer should be more closely monitored. The FDA’s precaution can be viewed on their website by clicking here.
Contact the Law Offices of d’Oliveira & Associates, P.C.
If you or a loved one was diagnosed with breast cancer while on, or recently after discontinuing use of, the birth control shot Depo-Provera, you may want to speak with a Depo-Provera Lawyer regarding a potential claim. An injury attorney familiar with new developments in the investigation of this contraceptive may be able to help you make important personal and legal decisions. d’Oliveira & Associates is working with experienced lawyers across the country who are handling these cases.
Call d’Oliveira & Associates at 1-800-992-6878 or fill out a contact form for your free legal consultation.